Elyra Kidney Stone Laser Launch Tests Becton Dickinson Execution Story
Becton Dickinson (NYSE:BDX) has launched the Elyra Thulium Fiber Laser System for kidney stone procedures, expanding its urologic stone management por...
Becton Dickinson (NYSE:BDX) has launched the Elyra Thulium Fiber Laser System for kidney stone procedures, expanding its urologic stone management por...
Bullish
BD (Becton, Dickinson and Company) has launched the Elyra Thulium Fiber Laser (TFL) System, an advanced medical device designed to improve efficiency ...
Neutral
Becton Dickinson (BD), a leading medical device company, is integrating AI and automation with "lean manufacturing" principles to boost efficiency and...
Bullish
BD (Becton, Dickinson and Company) has launched the Elyra™ Thulium Fiber Laser (TFL) System, designed to enhance kidney stone care for urology teams. ...
Bullish
BD (Becton, Dickinson and Company) has appointed Peter Menziuso as executive vice president and president of BD Interventional, effective June 1. Menz...
Bullish
BD (Becton, Dickinson and Company) announced Peter Menziuso as the new executive vice president and president of BD Interventional, effective June 1. ...
Neutral
ABC Arbitrage SA decreased its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 72.3% during the 4th quarter, according to its mo...
Becton Dickinson (BDX) recently appointed Vitor Roque as CFO and raised its full-year adjusted EPS guidance after exceeding Q2 expectations. This lead...
Bullish
Becton Dickinson has released its latest quarterly results, reporting approximately $4.7 billion in revenue and adjusted earnings per share of $2.10 f...
Bullish
Waters Corporation announced strong first-quarter 2026 financial results, including double-digit organic growth, after integrating its recently acquir...
Becton Dickinson (BDX) has shown mixed share performance recently, but Simply Wall St's analysis suggests the stock is undervalued. A Discounted Cash ...
Becton Dickinson (BDX) reported a mixed Q2 2026, with revenue of US$4.7 billion and a basic EPS loss of US$0.13, partly due to a US$274 million loss f...
Neutral
Becton Dickinson's stock climbed after the medical device maker surpassed second-quarter profit and revenue estimates, subsequently raising its full-y...
Bullish
BD (Becton, Dickinson and Company) announced a partnership with Wellstar Health System to enhance medication delivery safety and quality through AI-po...
Neutral
Danske Bank A S increased its stake in Becton, Dickinson and Company by 56.9% in the fourth quarter, bringing its total holdings to 289,926 shares val...
Neutral
Becton Dickinson reported strong Q2 fiscal 2026 results with revenue reaching $5.2 billion, a 4.7% increase year-over-year, and adjusted EPS up 8.2% t...
Becton Dickinson (BDX) has experienced prolonged share price weakness, with its stock broadly flat over the last month and down significantly year-to-...